Leap Therapeutics Stock Forecast - Period Momentum Indicator

LPTX Stock  USD 3.19  0.02  0.63%   
Leap Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Leap Therapeutics stock prices and determine the direction of Leap Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Leap Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of Leap Therapeutics to cross-verify your projections.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.
  
Leap Therapeutics has current Period Momentum Indicator of 0.02.
Most investors in Leap Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Leap Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Leap Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Leap Therapeutics VolatilityBacktest Leap TherapeuticsInformation Ratio  

Leap Therapeutics Trading Date Momentum

On May 06 2024 Leap Therapeutics was traded for  3.19  at the closing time. The top price for the day was 3.28  and the lowest listed price was  3.01 . There was no trading activity during the period 0.0. Lack of trading volume on May 6, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.51% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Leap Therapeutics to competition

Other Forecasting Options for Leap Therapeutics

For every potential investor in Leap, whether a beginner or expert, Leap Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Leap Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Leap. Basic forecasting techniques help filter out the noise by identifying Leap Therapeutics' price trends.

Leap Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Leap Therapeutics stock to make a market-neutral strategy. Peer analysis of Leap Therapeutics could also be used in its relative valuation, which is a method of valuing Leap Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Leap Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Leap Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Leap Therapeutics' current price.

Leap Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Leap Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Leap Therapeutics shares will generate the highest return on investment. By undertsting and applying Leap Therapeutics stock market strength indicators, traders can identify Leap Therapeutics entry and exit signals to maximize returns.

Leap Therapeutics Risk Indicators

The analysis of Leap Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Leap Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting leap stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Leap Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Leap Therapeutics' short interest history, or implied volatility extrapolated from Leap Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Leap Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Leap Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Leap Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Leap Therapeutics Stock:
Check out Historical Fundamental Analysis of Leap Therapeutics to cross-verify your projections.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Leap Stock analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Leap Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Leap Therapeutics. If investors know Leap will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Leap Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Leap Therapeutics is measured differently than its book value, which is the value of Leap that is recorded on the company's balance sheet. Investors also form their own opinion of Leap Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Leap Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Leap Therapeutics' market value can be influenced by many factors that don't directly affect Leap Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Leap Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Leap Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Leap Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.